Elekta optimizes treatment times for cancer patients via proactive service innovation
Elekta has invested heavily in digitized service solutions to ensure timely radiotherapy for cancer patients. Their IntelliMax® system remotely monitors over 80% of installed linear accelerators, preventing issues and ensuring seamless operations. Recently, Elekta received its first patent for IntelliMax capabilities, which are expected to enhance serviceability and predictability in treatment systems. In 2020, IntelliMax contributed to maintaining over 200,000 patient treatment slots. This innovation aligns with Elekta's Access 2025 strategy, focusing on proactive maintenance and customer partnerships.
- Elekta received its first patent for IntelliMax capabilities enhancing serviceability.
- IntelliMax ensured over 200,000 patient treatment slots remained uninterrupted in 2020.
- The service innovation aligns with Elekta's Access 2025 strategy for proactive maintenance.
- None.
STOCKHOLM, July 7, 2021 /PRNewswire/ -- For the last several years, Elekta (EKTA-B.ST) has invested substantially in digitized service solutions to keep critical treatment machines up and running at cancer clinics, thereby ensuring that patients receive timely radiotherapy. Among these solutions is the remote exchange of technical system data between Elekta remote service centers and linear accelerators installed at hospitals worldwide.
Using Elekta IntelliMax® real-time, remote system data monitoring, Elekta keeps a watchful eye on more than 80 percent of the company's linear accelerators installed around the world. IntelliMax constantly tracks these systems' functionality and technical status to ensure timely prevention or repair of issues. Elekta recently received its first patent for an IntelliMax capability that can help radiotherapy departments preserve the functionality of a crucial component of the technology used to treat patients.
Service innovation supports Access 2025 strategy
"Innovations such as IntelliMax are in harmony with our overall service strategy," says Paul Bergström, Executive Vice President, Global Service. "As our technology advances, it is critical to ensure its serviceability and maintenance progresses. Elekta is changing the equipment service paradigm – rather than responding reactively, our service model is centered on our strategy of lifelong partnership with our customers, proactively ensuring treatment systems are available when needed. Through IntelliMax, we can attend to systems during hours when it's convenient to our customers and, through this, create increased access for patients."
IntelliMax enables remote as well as onsite proactive system maintenance. In 2020, IntelliMax ensured that more than 200,000 patient treatment slots could continue without interruption.
"This patent for Elekta service is a fantastic milestone on our digitalization journey," adds Paul Bergström. "It is the first of several pending patent applications focused on improving the serviceability of our solutions. We are going to improve the 'predictability-to-treat' for customers – in other words, giving them the certainty that the treatment system is available for clinical use if and when they need it for life-saving, life-prolonging cancer treatments."
Learn more about IntelliMax at elekta.com/IntelliMax.
For further information, please contact:
Mattias Thorsson, Vice President, Head of Corporate Communications
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time
Raven Canzeri, Global Director, Media Relations
Tel: +1 770-670-2524, e-mail: Raven.Canzeri@elekta.com
Time zone: ET: Eastern Time
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,400 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
IntelliMax flight tube patent_final |
View original content:https://www.prnewswire.com/news-releases/elekta-optimizes-treatment-times-for-cancer-patients-via-proactive-service-innovation-301326624.html
SOURCE Elekta
FAQ
What is Elekta's IntelliMax® system?
How has Elekta's IntelliMax® impacted patient treatment?
What recent patent did Elekta receive?
How does IntelliMax® align with Elekta's business strategy?
